Jiangzhong Pharmaceutical News

Jiangzhong Pharmaceutical (600750): Chinese OTC leader in gastrointestinal category

htscNov 12 00:00

Jiangzhong Pharmaceutical (600750): The profit side reported steady growth in the third quarter, and the health business needs to resume

china great wall securitiesOct 28 00:00

Jiangzhong Pharmaceutical (600750): Responding to policy guidance to increase holdings shows confidence in development

china great wall securitiesOct 22 00:00

Jiangzhong Pharmaceutical (600750): H1 performance remained stable and OTC gross profit increased

Northeast SecuritiesSep 2 00:00

Jiangzhong Pharmaceutical (600750): Steady growth in performance starts mid-term dividends

Guotou SecuritiesAug 22 07:42

Jiangzhong Pharmaceutical (600750): Profit growth slows in 2024Q2 and actively carries out cash dividends

china great wall securitiesAug 22 00:00

Jiangzhong Pharmaceutical (600750): Under short-term pressure from a high revenue base, profit growth in the main business exceeded expectations

May 4 11:12

Jiangzhong Pharmaceutical (600750): Profit growth under the 2024Q1 high base, “improving quality, efficiency, and valuing return” actions are imminent

May 3 00:00

Jiangzhong Pharmaceutical (600750): Under high base, 24Q1 performance is under pressure in the short term, OTC business is growing steadily

Sinolink Securities.Apr 30 00:00

Jiangzhong Pharmaceutical (600750): Gastrointestinal category leader's “high dividend+state-owned enterprise” value reshaping

Southwest SecuritiesApr 10 00:00

Jiangzhong Pharmaceutical (600750): Improving Quality and Efficiency, High Growth, Brand Building Results Remarkable

Apr 6 00:00

Jiangzhong Pharmaceutical (600750): Performance is in line with expectations, high dividends, high quality assets

Mar 24 00:00

Jiangzhong Pharmaceutical (600750): Steady performance growth, “high dividend+state-owned enterprise” investment value highlighted

Jan 30 00:00

Jiangzhong Pharmaceutical (600750): Profitability continues to improve with the concerted efforts of the three business sectors

Nov 20, 2023 00:00

Jiangzhong Pharmaceutical (600750): The three major sectors in Q3 remained flat year on year, and high dividends highlight long-term value

Nov 11, 2023 00:00

Jiangzhong Pharmaceutical (600750): Q3 quarterly revenue under short-term pressure, cost optimization driving high profit growth

Oct 31, 2023 09:42

Jiangzhong Pharmaceutical (600750): Focus on three key business layouts and achieve steady growth in H1 core categories

中信建投證券Aug 26, 2023 00:00

Jiangzhong Pharmaceutical (600750): The company's performance is growing steadily, and gross margin is steadily increasing

國海證券Aug 24, 2023 14:46

Jiangzhong Pharmaceutical (600750): Semi-annual performance growth is steady and core products continue to be released

華安證券Aug 24, 2023 00:00

Jiangzhong Pharmaceutical (600750): Endogenous cultivation extends the second growth curve, China Resources empowers and increases ROE

長城證券Mar 29, 2023 00:00